Chemitope Glycopeptide
Chemitope specializes in the chemical synthesis of complex glycopeptides for use in challenging vaccine applications, such as HIV. Team: Baptiste Aussedat, PhD William Walkowicz, PhD
Read MoreLysimmune BioScience
Platform technology to produce recombinant therapeutic antibodies against Staphylococcus aureus and other pathogens, targeting cell wall carbohydrates not adequately recognized by the human immune system. Team: Assaf Raz, PhD – CSO Vincent A. Fischetti, PhD – Head of SAB
Read MoreCalRegen, Inc.
CalRegen, Inc is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.…
Read MoreYouMatter
YouMatter is a digital app that addresses the gap between treatment and self-learning in order to help prevent suicide. Team: Amanda Wang, Founder Melissa Arbuckle, MD, PhD, Head Advisor
Read MoreTEZCAT Biologics
TEZCAT is developing a biologics-based therapeutic approach to treat mutant Ras cancers, such as colorectal cancer. TEZCAT team: CEO – Alex Efron CSO – Craig Ramirez, Ph.D. Ops. Mgr – Andy Hauser, Ph.D.
Read MoreVesselon
Vesselon, Inc. is developing novel therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as the backbone of its encapsulated drug/drug platform technology. Furthermore, the complexes are formed at the time of administration (rather than at the drug manufacturing stage) enabling the creation of…
Read MoreAlloMek
AlloMek is working on a small molecule based therapeutics for rare diseases. AlloMek Team: Uday Khire, Ph.D. MBA Co-Founder and CEO
Read MoreLambda Vision, Inc.
LambdaVision, Inc. is commercializing a retinal implant to restore vision for the millions of patients suffering from retinitis pigmentosa (RP) and age-related macular degeneration (AMD). LambdaVision, Inc. Team: Nicole L. Wagner, PhD, CEO Jordan A. Greco, PhD, CSO
Read MoreCytosolix
Cytosolix is developing a small-molecule tumor targeted chemotherapy platform. Cytosolix Team: John C. Deacon, Ph.D., Founder and President
Read More